Targeting autophagy overcomes enzalutamide resistance in castrate-resistant prostate cancer cells and improves therapeutic response in a xenograft model

被引：0
|
作者：
Yang, Joy C. [1 ]
Nguyen, Hao G. [2 ]
Kung, Hsing-Jien [1 ]
Shi, Xu-Bao [1 ]
Tilki, Derya [1 ]
White, Ralph W. deVere [1 ]
Gao, Allen C. [1 ]
Evans, Christopher P. [1 ]
机构：
[1] UC Davis Med Ctr, Sacramento, CA USA
[2] UCSF Med Ctr, San Francisco, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
327
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Validation of imaging-based biomarkers of treatment response in patients with metastatic castrate-resistant prostate cancer treated with enzalutamide.
    Liu, Glenn
    Tomlins, Scott A.
    Harmon, Stephanie
    Perlman, Scott
    Simoncic, Urban
    Eickhoff, Jens C.
    Staab, Mary Jane
    Tuite, Michael
    Jeraj, Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] AbirateroneDevelopment of abiraterone resistance in castrate-resistant prostate cancer: 2 case reports
    Reactions Weekly, 2017, 1675 (1) : 14 - 14
  • [33] Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
    Quan Wang
    Wei-Yang He
    Yi-Zhou Zeng
    Arman Hossain
    Xin Gou
    International Urology and Nephrology, 2018, 50 : 675 - 686
  • [34] Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
    Wang, Quan
    He, Wei-Yang
    Zeng, Yi-Zhou
    Hossain, Arman
    Gou, Xin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (04) : 675 - 686
  • [35] What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?
    Davies, Rhian Sian
    Smith, Christian
    Button, Michael Robert
    Tanguay, Jacob
    Barber, Jim
    Palaniappan, Nachiappan
    Staffurth, John
    Lester, Jason Francis
    ANTICANCER RESEARCH, 2015, 35 (10) : 5615 - 5621
  • [36] WNT/β-CATENIN SIGNALLING IS A POTENTIAL THERAPEUTIC TARGET FOR CASTRATE-RESISTANT PROSTATE CANCER.
    Kawano, Yoshiaki
    Maeda, Yoshihiro
    Motoshima, Takanobu
    Imamura, Takahisa
    Takahashi, Wataru
    Wada, Yoshihiro
    Kypta, Robert
    Eto, Masatoshi
    JOURNAL OF UROLOGY, 2014, 191 (04): : E504 - E505
  • [37] Zyflamend Reduces the Expression of Androgen Receptor in a Model of Castrate-Resistant Prostate Cancer
    Huang, E-Chu
    Chen, Guoxun
    Baek, Seung Joon
    McEntee, Michael F.
    Collier, J. Jason
    Minkin, Steven
    Biggerstaff, John
    Whelan, Jay
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2011, 63 (08): : 1287 - 1296
  • [38] The Needle in the Haystack: The Presence of Castrate-resistant Prostate Cancer Cells in Hormone-naive Prostate Cancer
    Ali, Amin
    Baena, Esther
    EUROPEAN UROLOGY, 2022, 81 (05) : 456 - 457
  • [39] Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
    Wang, Jinxiang
    Zeng, Leli
    Wu, Nisha
    Liang, Yanling
    Jin, Jie
    Fan, Mingming
    Lai, Xiaoju
    Chen, Zhe-Sheng
    Pan, Yihang
    Zeng, Fangyin
    Deng, Fan
    DRUG RESISTANCE UPDATES, 2023, 70
  • [40] Association of Overall Survival with Glycolytic Activity of Castrate-Resistant Prostate Cancer Metastases Response
    Vargas, Hebert Alberto
    Wassberg, Cecilia
    Fox, Josef J.
    Wibmer, Andreas
    Goldman, Debra A.
    Kuk, Deborah
    Gonen, Mithat
    Larson, Steven M.
    Morris, Michael J.
    Scher, Howard I.
    Hricak, Hedvig
    RADIOLOGY, 2015, 274 (02) : 625 - 625
12345